Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer (ProLung)
Evaluate the Utility of the ProLung China Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer
Sponsor: Chinese Alliance Against Lung Cancer
Listed as NCT02726633, this observational or N/A phase trial focuses on Multiple Pulmonary Nodules and Solitary Pulmonary Nodule and remains ongoing. Sponsored by Chinese Alliance Against Lung Cancer, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
May 2019 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2019 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Alliance Against Lung Cancer
For direct contact, visit the study record on ClinicalTrials.gov .